Hendrik C. Dienemann

Correction to: Dexamethasone-induced cisplatin and gemcitabine resistance in lung carcinoma samples treated ex vivo.

Journal: British journal of cancer

Published: September 18, 2023

Differentially methylated regions within lung cancer risk loci are enriched in deregulated enhancers.

Journal: Epigenetics

Published: February 17, 2021

Perioperative course and quality of life in a prospective randomized multicenter phase III trial, comparing standard lobectomy versus anatomical segmentectomy in patients with non-small cell lung cancer up to 2 cm, stage IA (7th edition of TNM staging system).

Journal: Lung cancer (Amsterdam, Netherlands)

Published: April 25, 2019

Lung cancer mortality reduction by LDCT screening-Results from the randomized German LUSI trial.

Journal: International journal of cancer

Published: March 08, 2019

Procedure-Specific Risk Prediction for Recurrence in Patients Undergoing Lobectomy or Sublobar Resection for Small (≤2 cm) Lung Adenocarcinoma: An International Cohort Analysis.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: July 02, 2018

Circulating and Tumor Myeloid-derived Suppressor Cells in Resectable Non-Small Cell Lung Cancer.

Journal: American journal of respiratory and critical care medicine

Published: April 05, 2018

Molecular signatures in IASLC/ATS/ERS classified growth patterns of lung adenocarcinoma.

Journal: PloS one

Published: April 04, 2018

Expression ratio of the TGFβ-inducible gene MYO10 is prognostic for overall survival of squamous cell lung cancer patients and predicts chemotherapy response.

Journal: Scientific reports

Published: March 26, 2018

Implementation of Hyperthermic Intrathoracic Chemotherapy (HITHOC) in Germany

Journal: Zentralblatt fur Chirurgie

Published: March 13, 2018

The combination of the blood based tumor biomarkers cytokeratin 19 fragments (CYFRA 21-1) and carcinoembryonic antigen (CEA) as a potential predictor of benefit from adjuvant chemotherapy in early stage squamous cell carcinoma of the lung (SCC).

Journal: Lung cancer (Amsterdam, Netherlands)

Published: January 24, 2018

Evaluation of NGS and RT-PCR Methods for ALK Rearrangement in European NSCLC Patients: Results from the European Thoracic Oncology Platform Lungscape Project.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: September 08, 2017

C-reactive protein-albumin ratio is an independent prognostic predictor of tumor recurrence in stage IIIA-N2 lung adenocarcinoma patients.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: August 22, 2017

Correction to: Dexamethasone-induced cisplatin and gemcitabine resistance in lung carcinoma samples treated ex vivo.

Correction to: Dexamethasone-induced cisplatin and gemcitabine resistance in lung carcinoma samples treated ex vivo.

Differentially methylated regions within lung cancer risk loci are enriched in deregulated enhancers.

Differentially methylated regions within lung cancer risk loci are enriched in deregulated enhancers.

Perioperative course and quality of life in a prospective randomized multicenter phase III trial, comparing standard lobectomy versus anatomical segmentectomy in patients with non-small cell lung cancer up to 2 cm, stage IA (7th edition of TNM staging system).

Perioperative course and quality of life in a prospective randomized multicenter phase III trial, comparing standard lobectomy versus anatomical segmentectomy in patients with non-small cell lung cancer up to 2 cm, stage IA (7th edition of TNM staging system).

Lung cancer mortality reduction by LDCT screening-Results from the randomized German LUSI trial.

Lung cancer mortality reduction by LDCT screening-Results from the randomized German LUSI trial.

Procedure-Specific Risk Prediction for Recurrence in Patients Undergoing Lobectomy or Sublobar Resection for Small (≤2 cm) Lung Adenocarcinoma: An International Cohort Analysis.

Procedure-Specific Risk Prediction for Recurrence in Patients Undergoing Lobectomy or Sublobar Resection for Small (≤2 cm) Lung Adenocarcinoma: An International Cohort Analysis.

Circulating and Tumor Myeloid-derived Suppressor Cells in Resectable Non-Small Cell Lung Cancer.

Circulating and Tumor Myeloid-derived Suppressor Cells in Resectable Non-Small Cell Lung Cancer.

Molecular signatures in IASLC/ATS/ERS classified growth patterns of lung adenocarcinoma.

Molecular signatures in IASLC/ATS/ERS classified growth patterns of lung adenocarcinoma.

Expression ratio of the TGFβ-inducible gene MYO10 is prognostic for overall survival of squamous cell lung cancer patients and predicts chemotherapy response.

Expression ratio of the TGFβ-inducible gene MYO10 is prognostic for overall survival of squamous cell lung cancer patients and predicts chemotherapy response.

Implementation of Hyperthermic Intrathoracic Chemotherapy (HITHOC) in Germany

Implementation of Hyperthermic Intrathoracic Chemotherapy (HITHOC) in Germany

The combination of the blood based tumor biomarkers cytokeratin 19 fragments (CYFRA 21-1) and carcinoembryonic antigen (CEA) as a potential predictor of benefit from adjuvant chemotherapy in early stage squamous cell carcinoma of the lung (SCC).

The combination of the blood based tumor biomarkers cytokeratin 19 fragments (CYFRA 21-1) and carcinoembryonic antigen (CEA) as a potential predictor of benefit from adjuvant chemotherapy in early stage squamous cell carcinoma of the lung (SCC).

Evaluation of NGS and RT-PCR Methods for ALK Rearrangement in European NSCLC Patients: Results from the European Thoracic Oncology Platform Lungscape Project.

Evaluation of NGS and RT-PCR Methods for ALK Rearrangement in European NSCLC Patients: Results from the European Thoracic Oncology Platform Lungscape Project.

C-reactive protein-albumin ratio is an independent prognostic predictor of tumor recurrence in stage IIIA-N2 lung adenocarcinoma patients.

C-reactive protein-albumin ratio is an independent prognostic predictor of tumor recurrence in stage IIIA-N2 lung adenocarcinoma patients.

Perioperative course and quality of life in a prospective randomized multicenter phase III trial, comparing standard lobectomy versus anatomical segmentectomy in patients with non-small cell lung cancer up to 2 cm, stage IA (7th edition of TNM staging system).

Perioperative course and quality of life in a prospective randomized multicenter phase III trial, comparing standard lobectomy versus anatomical segmentectomy in patients with non-small cell lung cancer up to 2 cm, stage IA (7th edition of TNM staging system).